Breast Imaging Market (2025 - 2030)

Breast Imaging Market Summary

The global breast imaging market size was estimated at USD 5.45 billion in 2024 and is projected to reach USD 9.00 billion by 2030, growing at a CAGR of 8.9% from 2025 to 2030. Factors such as the rising prevalence of breast cancer, technological breakthroughs in the domain of breast imaging, and investment from several organizations in breast cancer screening programs drive the breast imaging market.

According to the World Cancer Research Fund (WCRF), by 2030, the number of cases of breast cancer is expected to reach about 2.1 million globally. According to a new report from the International Agency for Research on Cancer (IARC), breast cancer cases are expected to increase by 38 percent globally by 2050, with annual deaths from the disease projected to rise by 68 percent. This aspect is expected to contribute to the growth of the breast imaging market over the forecast period.

The growing prevalence of breast cancer and other breast-related abnormalities is expected to drive the expansion of the breast imaging market significantly. According to data published by the National Breast Cancer Foundation, Inc. in June 2025, approximately 1 in 8 women in the U.S. is expected to be diagnosed with breast cancer during their lifetime. In addition, projections from the International Agency for Research on Cancer estimate a 27.8% increase in breast cancer incidence in the U.S. between 2022 and 2050, with cases expected to reach approximately 350,693 by 2050. This substantial rise in cancer cases is anticipated to fuel the demand for breast magnetic resonance imaging procedures across the country.

Widespread research in the development of hybrid imaging systems provides high growth opportunities and also aids the market growth. Recent developments in imaging technology have completely revolutionized the nature of treatment and how it is approached. To view the metabolic data and anatomical characteristics of the organs, it has become more crucial to combine imaging methods such as CT scans, MRIs, PET, and others. Furthermore, the quality of breast pictures, patient comfort, and patient dose have all been enhanced by these integrated imaging modalities. Thereby, owing to these advantages, manufacturers across the globe are concentrating more on the introduction of new products to improve the sensitivity and precision of breast cancer diagnostics. For instance, in January 2021, Seno Medical Instruments obtained premarket approval from The Center for Devices and Radiological Health in the U.S. for its diagnostic breast cancer imaging technology. The novel technology specialized in differentiating malignant and benign breast lesions.

Furthermore, the increasing number of clinical trials aimed at evaluating advanced magnetic resonance imaging modalities for cancer detection and developing innovative imaging solutions is expected to contribute significantly to the growth of the breast imaging market. These trials are crucial in improving diagnostic accuracy, enhancing early detection, and validating new technologies.

Table 1 Ongoing and Recently Conducted Clinical Trials for Breast Cancer MRI in the U.S.

Such ongoing trials evaluating various MRI modalities for breast cancer are anticipated to create significant growth opportunities for industry stakeholders. These studies advance the understanding of imaging technologies and pave the way for the development of more precise, cost-effective, and patient-friendly diagnostic solutions, ultimately enhancing clinical outcomes and market potential.

Market Concentration & Characteristics

The breast imaging market demonstrates high innovation, driven by rapid advancements in imaging technologies and AI integration. Companies focus on developing modalities that enhance diagnostic accuracy, reduce false positives, and enable early cancer detection. Innovations such as digital breast tomosynthesis (3D mammography), contrast-enhanced mammography, molecular breast imaging, and AI-powered image analysis tools are reshaping clinical workflows. Furthermore, the adoption of hybrid technologies combining ultrasound and mammography and the growing use of cloud-based platforms for image sharing and analysis enable a more precise and patient-centric approach to breast cancer screening and diagnosis.

M&A activity in the breast imaging market has been moderately high, as major players pursue strategic collaborations to strengthen their technological portfolios and expand their geographic presence. Established imaging companies are acquiring startups and AI-focused firms to integrate advanced analytics and automation into their systems.

Regulations have a significant effect on the breast imaging market, influencing product development, approval timelines, and clinical adoption. Stringent regulatory frameworks, particularly in the U.S. (FDA) and Europe (MDR/CE marking), ensure the safety, efficacy, and quality of imaging systems and AI-based diagnostic tools. While these regulations promote patient safety and standardization, they can also increase the cost and duration of bringing new technologies to market.

Technology Insights

The ionizing segment dominates the breast imaging market in 2024. It is expected to register the fastest CAGR over the forecast period, primarily due to its proven diagnostic accuracy and widespread clinical adoption. Technologies such as mammography, digital breast tomosynthesis, and contrast-enhanced mammography remain the gold standard for breast cancer screening and early detection. These modalities provide high-resolution images that accurately identify microcalcifications and subtle lesions, making them indispensable in routine screening programs. Continuous advancements in ionizing imaging technologies, such as low-dose radiation systems, enhanced image processing software, and AI integration for improved interpretation, drive their demand further. In addition, the growing prevalence of breast cancer, coupled with government-led screening initiatives and reimbursement support for mammography, continues to strengthen the dominance and growth potential of the ionizing segment in the global breast imaging market.

The non-ionizing segment of the breast imaging market is experiencing growth, driven by the rising demand for safer, radiation-free diagnostic alternatives and advancements in imaging accuracy. Technologies such as breast ultrasound, magnetic resonance imaging, elastography, and optical imaging are increasingly being adopted, particularly for younger women and patients with dense breast tissue, where traditional mammography may be less effective. The growing preference for supplemental and adjunctive imaging techniques that improve lesion characterization and reduce false positives fuels this segment’s expansion. Moreover, automated breast ultrasound (ABUS) and contrast-enhanced MRI enhance diagnostic precision and workflow efficiency. The shift toward personalized and preventive healthcare, along with improved image resolution, portability, and cost efficiency, further accelerates the growth of non-ionizing breast imaging technologies globally.

End-use Insights

Hospitals dominated the end use segment in 2022 with a share of 42.2% in terms of revenue. The presence of advanced and well-equipped breast imaging facilities within a hospital positively affect various factors, such as duration of hospital stay, total healthcare cost, quality of care, and availability of emergency care. For instance, in September 2019, Parkside Hospital in Wimbledon installed a 3Dmammography system from Hologic that enables high-resolution breast tomosynthesis. As investments in healthcare structures have increased over the world, this trend will aid in market expansion in the next years. Investing has enabled the procurement of improved infrastructure and diagnostic equipment. It has also been effective in providing good health coverage in all hospital-based health care services. These are the key factors that will contribute to hospital segment growth in the next years.

Large-scale hospitals usually have in-house breast imaging facilities; however, the requirement of high investments & frequent maintenance, space, and skilled professionals can act as an entry barrier. This can burden hospitals trying to manage their medical imaging facilities. To reduce this burden and to increase the reach of their facilities and services, hospitals can partner up with diagnostic imaging centers for providing medical imaging facilities.

The breast care centers segment is expected to grow at the fastest CAGR over the forecast period, driven by the rising focus on specialized, patient-centric diagnostic care and comprehensive breast health management. These centers offer integrated diagnostic, screening, and treatment services under one roof, improving patient convenience and clinical outcomes. The increasing prevalence of breast cancer and growing awareness about early detection have led to a higher influx of patients seeking specialized imaging and consultation services at these centers. Moreover, advancements in digital imaging, AI-based diagnostics, and tele-radiology enable breast care centers to deliver faster, more accurate, and personalized results. Supportive government screening programs, favorable reimbursement structures, and collaborations between hospitals and diagnostic networks further propel their expansion.

Regional Insights

North America breast imaging market dominated the breast imaging market in 2024 and is expected to exhibit a considerable growth rate over the forecast period. The rising number of breast cancer cases in this region is adding to the growth of the breast imaging market. For instance, in Canada alone, approximately 2,214,157 publicly funded MRI examinations were conducted during the 2022-2023 fiscal year, reflecting the scale of imaging utilization. These factors are expected to significantly propel the growth of the breast imaging market across North America.

U.S. Breast Imaging Market Trends

The U.S. breast imaging market is witnessing significant growth, driven by increasing breast cancer prevalence, rapid technological advancements, and evolving screening guidelines that promote early detection. In 2025, 316,950 women expected to be diagnosed with invasive breast cancer, with 59,080 new cases of ductal carcinoma in situ. The U.S. has one of the most established breast cancer screening programs globally, with growing emphasis on personalized screening approaches based on breast density and patient risk profiles. Government and healthcare initiatives to lower the recommended screening age and mandate breast density notifications have significantly boosted demand for ionizing and non-ionizing imaging modalities. Moreover, continuous innovation-such as integrating artificial intelligence for image analysis, contrast-enhanced MRI, and automated breast ultrasound systems- improves diagnostic precision and reduces false positives.

Europe Breast Imaging Market Trends

The Europe breast imaging market is witnessing growth, driven by strong government screening programs, rising breast cancer prevalence, and rapid technological advancements. Europe remains the second-largest regional market globally, supported by national initiatives such as the EU’s Beating Cancer Plan, emphasizing widespread early screening and access to advanced diagnostic technologies. For instance, in March 2022, the European Society of Breast Imaging (EUSOBI) suggested breast MRI screening for women with extremely dense breast tissue, reinforcing the clinical value and demand for advanced imaging modalities across Europe. Countries such as Germany, France, and the UK lead in adopting digital mammography, 3D tomosynthesis, and breast MRI, while AI-powered diagnostic tools and computer-aided detection (CAD) systems are integrated into imaging workflows to enhance accuracy and efficiency.

Breast imaging market in the UK is experiencing notable growth, driven by government initiatives, technological advancements, and increasing public awareness. In the UK, cases are expected to rise from 58,756 cases annually in 2022 to 71,006 cases annually in 2050. The NHS Breast Screening Programme plays a central role in promoting early detection, while adopting digital mammography and 3D tomosynthesis has enhanced diagnostic accuracy. The integration of artificial intelligence is also a key development, with large-scale trials analyzing hundreds of thousands of mammograms to assess AI’s effectiveness in assisting radiologists, reducing workload, and expediting diagnoses. Rising breast cancer incidence, coupled with public education campaigns emphasizing the importance of regular screening, is further boosting demand for advanced imaging services. These factors are driving the expansion of the UK breast imaging market, strengthening early detection efforts and improving patient outcomes.

Asia Pacific Breast Imaging Market Trends

The Asia Pacific breast imaging market is experiencing growth, driven by rising breast cancer awareness, technological advancements, and expanding healthcare infrastructure. Countries such as India, China, Japan, and South Korea are leading this expansion, with initiatives to improve early detection and diagnostic accuracy. Technological innovations, including the adoption of digital mammography, 3D tomosynthesis, AI-based imaging protocols, and minimally invasive procedures, enhance both precision and accessibility of breast imaging services. Government-led screening programs, growing investments in healthcare facilities, and increased focus on preventive healthcare further support market growth.

The India breast imaging market is experiencing significant growth, driven by several interrelated factors. The rising incidence of breast cancer, particularly in urban areas, is a primary driver, fueled by lifestyle changes, delayed motherhood, and other demographic shifts. Government initiatives and awareness campaigns are crucial in promoting early detection, with programs and mobile health applications being deployed to increase screening accessibility. Technological advancements improve diagnostic accuracy and patient outcomes, including digital mammography, 3D tomosynthesis, and minimally invasive procedures like Vacuum Assisted Breast Biopsy (VABB).

Middle East & Africa Breast Imaging Market Trends

The MEA breast imaging market is experiencing growth, driven by increasing breast cancer awareness, expanding healthcare infrastructure, and government-led screening initiatives. Countries in the Gulf Cooperation Council (GCC) such as Saudi Arabia and the UAE are leading the market’s growth due to rising investments in advanced healthcare facilities and the adoption of modern imaging technologies like digital mammography, 3D tomosynthesis, and breast MRI. Awareness campaigns emphasizing early detection and preventive care are encouraging more women to undergo regular screenings, while public and private hospitals continue to upgrade imaging equipment to meet international standards.

Key players in the sector are increasing their research & development efforts to produce new technologies for breast imaging, which is fostering the market's expansion. For instance, the ATUSA from iSono Health, a portable system that automatically scans the entire breast and provides a three-dimensional image of the breast tissue, was approved by the U.S. FDA in May 2022. The rise in the adoption of such cutting-edge technologies in the region is contributing to the expansion of the breast imaging market during the projected period. Thus, the rising necessity for breast imaging technology coupled with growing investment in the health care department is likely to propel the market growth in this region.

However, the Asia-Pacific region will experience the fastest rate of growth in the global market. The increased prevalence of breast cancer, high R&D investments in breast cancer therapies, and developments in breast imaging modalities are the primary drivers driving the growth of the market. Breast cancer is the most frequent malignancy in most Asian countries regardless of race or ethnicity, according to the Centers for Disease Control and Prevention (CDC). According to GLOBOCAN 2018, the age-standardized incidence rate of breast cancer in Asia is 34.4 per 100,000 people. Thus, the increased prevalence of breast cancer and the region's expanding healthcare infrastructure are likely to fuel overall growth.

Presence of developing countries, such as China, Japan, and India, is anticipated to boost the breast imaging market growth in Asia Pacific region. In addition, key players are making constant efforts to enter emerging markets of Asia Pacific, which is expected to boost the breast imaging market over the forecast period.

Key Breast Imaging Company Insights

Breast imaging market is competitive and consists of several major players. In terms of market share, few major players currently dominate the market. However, with technological advancements and product modernizations, mid-size to smaller firms are increasing their market presence by launching new products and reducing the side effects of the procedures. The players in the market are striving to maintain their potential market share. Growing competition by means of technological improvements and new product developments leading to a reduction in the cost of the product is projected to boost the market.

Breast Imaging Market